EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sulforaphane prevents diabetes‐induced hepatic ferroptosis by activating Nrf2 signaling axis

Nevena Savic iD, Milica Markelic, Ana Stancic, Ksenija Velickovic iD, Ilijana Grigorov, Milica Vucetic, Vesna Martinovic, Andjelija Gudelj, Vesna Otasevic iD

BioFactors · 2024

DOI: 10.1002/biof.2042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BioFactors, 2024. Verfasst von Nevena Savic und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology, Institute for Biological Research "Siniša Stanković," National Institute of Republic of Serbia, University of Belgra…. Hauptthemen laut MEDLINE: Ferroptosis, Isothiocyanates, Sulfoxides, NF-E2-Related Factor 2. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Ministry of Science, Technological Development and Innovation of the Republic of Serbia, Science Fund of the Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Recently, we characterized the ferroptotic phenotype in the liver of diabetic mice and revealed nuclear factor (erythroid‐derived‐2)‐related factor 2 (Nrf2) inactivation as an integral part of hepatic injury. Here, we aim to investigate whether sulforaphane, an Nrf2 activator and antioxidant, prevents diabetes‐induced hepatic ferroptosis and the mechanisms involved. Male C57BL/6 mice were divided into four groups: control (vehicle‐treated), diabetic (streptozotocin‐induced; 40 mg/kg, from Days 1 to 5), diabetic sulforaphane‐treated (2.5 mg/kg from Days 1 to 42) and non‐diabetic sulforaphane‐treated group (2.5 mg/kg from Days 1 to 42). Results showed that diabetes‐induced inactivation of Nrf2 and decreased expression of its downstream antiferroptotic molecules critical for antioxidative defense (catalase, superoxide dismutases, thioredoxin reductase), iron metabolism (ferritin heavy chain (FTH1), ferroportin 1), glutathione (GSH) synthesis (cystine‐glutamate antiporter system, cystathionase, glutamate‐cysteine ligase catalitic subunit, glutamate‐cysteine ligase modifier subunit, glutathione synthetase), and GSH recycling ‐ glutathione reductase (GR) were reversed/increased by sulforaphane treatment. In addition, we found that the ferroptotic phenotype in diabetic liver is associated with increased ferritinophagy and decreased FTH1 immunopositivity. The antiferroptotic effect of sulforaphane was further evidenced through the increased level of GSH, decreased accumulation of labile iron and lipid peroxides (4‐hydroxy‐2‐nonenal, lipofuscin), decreased ferritinophagy and liver damage (decreased fibrosis, alanine aminotransferase, and aspartate aminotransferase). Finally, diabetes‐induced increase in serum glucose and triglyceride level was significantly reduced by sulforaphane. Regardless of the fact that this study is limited by the use of one model of experimentally induced diabetes, the results obtained demonstrate for the first time that sulforaphane prevents diabetes‐induced hepatic ferroptosis in vivo through the activation of Nrf2 signaling pathways. This nominates sulforaphane as a promising phytopharmaceutical for the prevention/alleviation of ferroptosis in diabetes‐related pathologies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisIsothiocyanatesSulfoxidesNF-E2-Related Factor 2Signal TransductionDiabetes Mellitus, ExperimentalMice, Inbred C57BLLiverAnimalsMiceMaleAntioxidantsOxidative Stress

Stichwörter der Autor:innen

GSH metabolismNrf2diabetesferritinophagyferroptosisiron metabolismliver pathologysulforaphane

Substanzen

sulforaphaneIsothiocyanatesSulfoxidesNF-E2-Related Factor 2Nfe2l2 protein, mouseAntioxidants

Autor:innen und Institutionen

  • Department of Molecular Biology, Institute for Biological Research "Siniša Stanković," National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.
  • Department of Cell and Tissue Biology, Faculty of Biology, University of Belgrade, Belgrade, Serbia.
  • Medical Biology Department, Centre Scientifique de Monaco (CSM), Monaco, Monaco.

ORCID-Profile: Nevena Savic, Ksenija Velickovic, Vesna Otasevic

Förderung

  • The Ministry of Science, Technological Development and Innovation of the Republic of Serbia
  • Science Fund of the Republic of Serbia

Zitieren

APA

Savic, N., Markelic, M., Stancic, A., Velickovic, K., Grigorov, I., Vucetic, M., Martinovic, V., Gudelj, A., & Otasevic, V. (2024). Sulforaphane prevents diabetes‐induced hepatic ferroptosis by activating Nrf2 signaling axis. BioFactors. https://doi.org/10.1002/biof.2042

Vancouver

Savic N, Markelic M, Stancic A, Velickovic K, Grigorov I, Vucetic M, et al. Sulforaphane prevents diabetes‐induced hepatic ferroptosis by activating Nrf2 signaling axis. BioFactors. 2024. doi:10.1002/biof.2042

BibTeX
@article{Savic2024,
  author = {Savic, Nevena and Markelic, Milica and Stancic, Ana and Velickovic, Ksenija and Grigorov, Ilijana and Vucetic, Milica and Martinovic, Vesna and Gudelj, Andjelija and Otasevic, Vesna},
  title = {Sulforaphane prevents diabetes‐induced hepatic ferroptosis by activating Nrf2 signaling axis},
  journal = {BioFactors},
  year = {2024},
  doi = {10.1002/biof.2042}
}
Kostenlos starten →